Helicobacter pylori is a widespread infectious disease most commonly associated with gastritis, peptic ulcer disease, and gastric cancer. The ability of this organism to influence immune function has been associated with a proinflammatory state that has been associated with several other conditions that can lead to significant mortality and morbidity. Treatment is possible with antibiotic regimens, however, increasing resistance requires treatment be informed by susceptibility information followed by a test of cure to ensure eradication of the infection. Given the global burden of this infection, it is important for providers to appropriately identify, diagnosis, and treat this condition to reduce the associated morbidity and mortality related to this condition.
No takes yet. Share an insight, caveat, or question.
Erin Raspet (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: